ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

Biopsy System Effective In Removing Benign Breast Masses, Study Finds

May 28, 2004

In Brief: Special Meeting To Review Viral Oncology Asked by DCCP Board; BCTF Budget: $8 Million

October 31, 1980

Breast Cancer Risk Prediction Improved In Atypia Cases

July 27, 2007

Joseph Simone Accepts Chief Physician Job At Memorial Hospital, Succeeding DeVita

February 21, 1992

M.D. Anderson Investigator Gave Drug To Patients Without IND; NCI Probes Incident, To Make Report

July 17, 1981

King Tells Centers To Concentrate On Project Grants

October 15, 1976